返回首页
  • [3cm≤大小>3cm] 肺癌疗效比较:3cm 日期:2020-03-01 22:57:39 点击:94 好评:0

    RFA - Local efficacy Median time to local tumor progression Simon CJ et al., Pulmonary Radiofrequency Ablation: Long-Term Safety and Efficacy in 153 Patients 2007, Radiology...

  • [肺癌消融禁忌症] 肺癌射频消融禁忌症 日期:2020-03-01 22:34:24 点击:195 好评:0

    PERCUTANEOUS ABLATIONS Clinical Criteria: Exclusion Contraindications: - Pulmonary hypertension - Malignant Effusion Abbas G, et al. Surg Oncol 2009;100(8):645-50 Relative contraindications: - Poor lung function: FEV11L respiratory failure...

  • [肺癌射频消融原理] 射频消融的原理 日期:2020-03-01 22:20:36 点击:65 好评:0

    Rational for ablation Its effective (technically, oncologically, economically, ...) Its minimally-invasive Its easy to perform and safe Its still constantly evolving (new generators, smaller applicators, computer-based treatment planning,...

  • [CIRSE:Guidelines] 欧洲C CIRSE 肺癌消融指南 日期:2020-03-01 22:02:44 点击:193 好评:0

    Invited Submission: CIRSE Standards of Practice Guidelines Published: 21 January 2012 Standards of Practice: Guidelines for Thermal Ablation of Primary and Secondary Lung Tumors...

  • [BACE(支气管动脉化疗性栓塞)] 肺癌:支气管动脉化疗性栓塞 日期:2020-03-01 18:35:37 点击:87 好评:0

    从60,70年代发展起来的这一技术,差不多算是一项古老的技术,曾经被证明对生存率没有影响的技术,几十年过去了,如今它 - Is it logical? - Is it dangerous? - Is it effective? Are there any study is to clarify these interrogative points(疑问点) an...

  • [研究报告标准化] 经皮肺癌热消融:研究报告的标准化 日期:2020-02-28 22:34:22 点击:158 好评:0

    纳入标准是为了界定被认为最有可能从实验疗法中获益的人群,因此排除了不在临床研究方案进行治疗的可能性...

  • [WCIO] 世界肿瘤介入大会:关于原发肺癌的热消融 日期:2020-02-28 22:18:15 点击:121 好评:0

    Thermal ablation is a safe therapeutic option to provide local control for 1 lung malignancies. Thermal ablation confers survival benefits in carefully selected patients: RF ablation with encouraging mid- and now long-term results. Studies...

  • [1和II期高危患者比较] I和II期高危NSCLC治疗比较 日期:2020-02-28 22:05:24 点击:194 好评:2

    RF Ablation Results: Comparative Therapies High-risk stage 1 and 2 NSCLC Modality 1-year 2-year 3-year 5-year LC DM Zemlyaketal SLR(25) 87.1% 12% 12% 3-ycancer-specific 90.6%,87.5%,90.2% 3-ycancer-free(p0.05) 60.8%,50%,45.6% RFA(12) 87.5%...

  • [I 期 NSCLC] 早期NSCLC治疗方式的比较 日期:2020-02-28 21:32:58 点击:86 好评:0

    RF Ablation Results: Comparative Therapies M odality 5-yearsurvival StageINSCLC LocalRecurrence (mostwithin2years) Lobarresection 60-80% 能手术尽手术 6.4% Sub-lobarresection 60-70% 17.2% Image-guidedablation 27% 22.2%1 Externalbeamradiatio...

  • [I期 NSCLC] I期 NSCLC 射频消融结果 日期:2020-02-28 21:23:38 点击:66 好评:0

    RF Ablation Results Pulmonary RFA: Long-term safety and efficacy in 153 patients1 - Local control group (n = 132) - 71 patients with stage I NSCLC - Overall survival rates: stage I NSCLC 78% 57% 36% 27% 27% 1-year 2-year 3-year 4-year 5-ye...